Fuchs (FPE3) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
3 Nov, 2025Executive summary
Sales for the first nine months of 2025 rose 1% year-over-year to €2,700 million, driven by both organic and external growth despite negative currency effects and a challenging economic environment.
EBIT for the period was €326 million, down 2% year-over-year, as higher costs outpaced sales growth, though Q3 EBIT improved 16% sequentially and slightly exceeded the prior year's Q3.
Free cash flow before acquisitions stood at €181 million, down 7% year-over-year but remained strong; net liquidity reduced to €30 million due to dividend payments and acquisitions.
The company confirms its full-year 2025 outlook, expecting sales, EBIT, and FVA to match the previous year's levels.
Financial highlights
Gross profit increased to €941 million, with gross margin improving to 34.9% year-to-date, up from 34.6% last year.
EBIT margin was 12.1%, down from 12.5% year-over-year.
Free cash flow before acquisitions was €181 million by September; investments totaled €47 million, up from €38 million year-over-year.
Net liquidity at September 2025 was €30 million, down from €228 million at December 2024, reflecting dividend payments and acquisitions.
CapEx remained stable at €51 million.
Outlook and guidance
Full-year 2025 guidance reaffirmed: sales revenues at €3,525 million, EBIT at €434 million, FVA at €245 million, and free cash flow before acquisitions around €260 million.
Q4 revenues and EBIT are expected to be broadly in line with the prior year.
Slightly higher volumes are expected to be offset by negative currency effects.
The company remains confident in its business foundation but acknowledges ongoing market uncertainty and the need for vigilance.
Additional measures are planned to address higher personnel and digitalization costs.
Latest events from Fuchs
- Record 2025 results and strong 2026 outlook, with growth tempered by rising uncertainties.FPE3
Q4 202520 Mar 2026 - 2025 saw resilient growth, strong cash flow, and ongoing strategic investment in innovation.FPE3
Investor presentation20 Mar 2026 - Record EBIT, 10% EPS growth, and a 23rd dividend increase highlight strong 2024 results.FPE3
Q4 20243 Feb 2026 - EBIT up 9% to €218M, margin at 12.4%, sales down 3%, outlook confirmed, LUBCON acquired.FPE3
Q2 20242 Feb 2026 - EBIT up 7% to €334M, margin at 12.5%, guidance confirmed, and LUBCON acquired.FPE3
Q3 202417 Jan 2026 - Accelerating growth and sustainability, targeting €500 mn EBIT by 2025 and net zero by 2050.FPE3
CMD 202411 Jan 2026 - Q1 2025 saw 5% sales growth and stable EBIT, led by Asia-Pacific gains.FPE3
Q1 202524 Dec 2025 - Sales up 2% but EBIT down 4%; full-year outlook revised amid cost and market pressures.FPE3
Q2 202516 Nov 2025